UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________

Form 6-K

___________________________________

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2024

Commission File Number 001-41576

___________________________________

ECARX Holdings Inc.

(Translation of registrant’s name into English)

___________________________________

5/F, Building 1, Zhongteng Building

2121 Longteng Avenue

Xuhui District, Shanghai 200232

People’s Republic of China

(Address of principal executive office)

___________________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒    Form 40-F ☐

EXHIBIT INDEX

Exhibit No.	Description
99.1	Press Release — ECARX Announces Fourth Quarter 2023 Financial Results

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ECARX Holdings Inc.
	By		/s/ Jing (Phil) Zhou
	Name	:	Jing (Phil) Zhou
	Title	:	Chief Financial Officer
Date: February 28, 2024